Fibronostics
In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.
Launch date
Employees
Market cap
-
Enterprise valuation
€29—44m (Dealroom.co estimates Aug 2020.)
Orlando Florida (HQ)
Financials
Estimates*
USD | 2022 | 2023 |
---|---|---|
Revenues | 1.1m | 1.1m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$8.0m | Series A | ||
* | N/A | $6.5m | Early VC |
Total Funding | €13.2m |
Related Content
Recent News about Fibronostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.